The medical device company, co-founded by Mark Gelfand and Howard R. Levin, M.D., offers a proprietary approach to treating hypertension, heart failure, diabetes, and renal failure through Carotid Body Modulation (CBM). Cibiem's catheter-based medical devices provide a minimally invasive way for doctors and medical professionals to treat fatal health disorders in an effective and efficient manner. Third Rock Ventures and SV Life Sciences are among the top-tier venture investors backing the company.